SYGMA 2
2018
Symbicort Given As Needed in Mild Asthma 2
In 4,215 patients with mild asthma, PRN budesonide-formoterol was non-inferior for severe exacerbations compared with daily maintenance budesonide plus PRN terbutaline.
Result
Efficacy: Annual rate of severe exacerbationsRR 0.97
Below 1 favours PRN budesonide-formoterol, above 1 favours daily maintenance budesonide plus PRN terbutaline.
Also reported: (non-inferior) with ~25% of the ICS dose.
- Subtopic
- PRN ICS-formoterol
- Design
- Multicentre RCT
- Relevance
- Important: one of several pillars.
- Cited in
- GINA 2021 Asthma
- Source
- Bateman ED, et al. N Engl J Med. 2018;378(20):1877-1887.doi 10.1056/NEJMoa1715275
Discussion & critique
Cemented PRN ICS-formoterol as an alternative to daily maintenance ICS in mild asthma.